Terns Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $102,558,000.
Profit Margin
| 2018 | 0 | -17.71M | |
|---|---|---|---|
| 2019 | 0 | -68.81M | |
| 2020 | 0 | -40.57M | |
| 2021 | 1M | -50.15M | -5015.8% |
| 2022 | 0 | -60.34M | |
| 2023 | 0 | -90.21M |
TERN Income Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 1M | 0 | 0 | 0 |
Cost of revenue | 881K | 1.03M | 512K | 394K | 195K | 0 |
Gross profit | -881K | -1.03M | 488K | -394K | -195K | 0 |
Operating exp. | ||||||
Research and development | 63.49M | 39.61M | 31.31M | 28.02M | 61.53M | 14.55M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 102.55M | 62.02M | 50.86M | 37.02M | 70.19M | 18.45M |
Operating income | -102.55M | -62.02M | -49.86M | -37.02M | -70.19M | -18.45M |
Other income (expenses), net | 12.58M | 2.04M | 210K | -2.73M | 1.35M | 38K |
Income before tax | -89.97M | -59.98M | -49.65M | -39.75M | -68.83M | -18.08M |
Income tax expense | 239K | 358K | 508K | 813K | -20K | -67K |
Net income | -90.21M | -60.34M | -50.15M | -40.57M | -68.81M | -17.71M |
Earnings per share | ||||||
Basic EPS | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
Diluted EPS | -1.27 | -1.67 | -1.98 | -1.61 | -2.74 | -0.74 |
| Data source | Data source | Data source | Data source |